NDC 0006-5423
BRIDION
Sugammadex
BRIDION is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Sugammadex Sodium.
| Product ID | 0006-5423_16317d73-43c1-4adc-8828-8d48f2998861 |
| NDC | 0006-5423 |
| Product Type | Human Prescription Drug |
| Proprietary Name | BRIDION |
| Generic Name | Sugammadex |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2015-12-15 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022225 |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | SUGAMMADEX SODIUM |
| Active Ingredient Strength | 100 mg/mL |
| Pharm Classes | gamma-Cyclodextrins [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
Packaging
NDC 0006-5423-12
10 VIAL, SINGLE-DOSE in 1 CARTON (0006-5423-12) > 2 mL in 1 VIAL, SINGLE-DOSE (0006-5423-02)
| Marketing Start Date | 2015-12-15 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 0006-5423-05 [00006542305]
BRIDION INJECTION, SOLUTION
| Marketing Category | NDA |
| Application Number | NDA022225 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2015-12-15 |
NDC 0006-5423-02 [00006542302]
BRIDION INJECTION, SOLUTION
| Marketing Category | NDA |
| Application Number | NDA022225 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2015-12-15 |
NDC 0006-5423-12 [00006542312]
BRIDION INJECTION, SOLUTION
| Marketing Category | NDA |
| Application Number | NDA022225 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2015-12-15 |
NDC 0006-5423-15 [00006542315]
BRIDION INJECTION, SOLUTION
| Marketing Category | NDA |
| Application Number | NDA022225 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2015-12-15 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| SUGAMMADEX SODIUM | 100 mg/mL |
OpenFDA Data
| SPL SET ID: | 5171d883-fe8f-482c-97ab-40b00975b64a |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Pharmacological Class
- gamma-Cyclodextrins [CS]
- gamma-Cyclodextrins [CS]
NDC Crossover Matching brand name "BRIDION" or generic name "Sugammadex"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0006-5423 | BRIDION | sugammadex |
| 0006-5425 | BRIDION | sugammadex |
| 71872-7187 | BRIDION | sugammadex |
Trademark Results [BRIDION]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 BRIDION 86588109 4979416 Live/Registered |
Merck Sharp & Dohme B.V. 2015-04-06 |
 BRIDION 86228696 4978527 Live/Registered |
Merck Sharp & Dohme B.V. 2014-03-21 |
 BRIDION 86228692 5223500 Live/Registered |
Merck Sharp & Dohme B.V. 2014-03-21 |
 BRIDION 85402383 not registered Dead/Abandoned |
MERCK SHARP & DOHME B.V. 2011-08-19 |
 BRIDION 79005765 3055628 Live/Registered |
MERCK SHARP & DOHME B.V. 2004-09-22 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.